ReP USP - Resultado da busca

Artigo de periodico
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial (2017)
Ohman, E. Magnus; Roe, Matthew T.; Steg, P. Gabriel; James, Stefan K.; Povsic, Thomas J.; White, Jennifer; Rockhold, Frank; Plotnikov, Alexei; Mundl, Hardi; Strony, John; Sun, Xiang; Husted, Steen; Tendera, Michal; Montalescot, Gilles; Bahit, M. Cecilia; Ardissino, Diego; Bueno, Héctor; Claeys, Marc J.; Nicolau, Jose C.; Cornel, Jan H.; Goto, Shinya; Kiss, Róbert Gábor; Güray, Ümit; Park, Duk-Woo; Bode, Christoph; Welsh, Robert C.; Gibson, C. Michael
Fonte: Lancet. Unidade: FM
Assuntos: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OHMAN, E. Magnus et al. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, v. 389, n. 10081, p. 1799-1808, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)30751-1. Acesso em: 12 nov. 2024.
APA
Ohman, E. M., Roe, M. T., Steg, P. G., James, S. K., Povsic, T. J., White, J., et al. (2017). Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, 389( 10081), 1799-1808. doi:10.1016/S0140-6736(17)30751-1
NLM
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Vancouver
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Artigo de periodico
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial (2017)
Prince, H. Miles; Kim, Youn H.; Horwitz, Steven M.; Dummer, Reinhard; Scarisbrick, Julia; Quaglino, Pietro; Zinzani, Pier Luigi; Wolter, Pascal; Sanches, Jose A.; Ortiz-Romero, Pablo L.; Akilov, Oleg E.; Geskin, Larisa; Trotman, Judith; Taylor, Kerry; Dalle, Stephane; Weichenthal, Michael; Walewski, Jan; Fisher, David; Dréno, Brigitte; Stadler, Rudolf; Feldman, Tatyana; MKuzel, Timothy; Wang, Yinghui; Palanca-Wessels, Maria Corinna; Zagadailov, Erin; Trepicchio, William L; Zhang, Wenwen; Lin, Hui-Min; Liu, Yi; Huebner, Dirk; Little, Meredith; Whittaker, Sean; Duvic, Madeleine
Fonte: Lancet. Unidade: FM
Assuntos: LINFOMA, ESTRATÉGIAS TERAPÊUTICAS, ANTINEOPLÁSICOS, MANIFESTAÇÕES CUTÂNEAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRINCE, H. Miles et al. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet, v. 390, n. 10094, p. 555-566, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)31266-7. Acesso em: 12 nov. 2024.
APA
Prince, H. M., Kim, Y. H., Horwitz, S. M., Dummer, R., Scarisbrick, J., Quaglino, P., et al. (2017). Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet, 390( 10094), 555-566. doi:10.1016/S0140-6736(17)31266-7
NLM
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, MKuzel T, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin H-M, Liu Y, Huebner D, Little M, Whittaker S, Duvic M. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial [Internet]. Lancet. 2017 ; 390( 10094): 555-566.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)31266-7
Vancouver
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, MKuzel T, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin H-M, Liu Y, Huebner D, Little M, Whittaker S, Duvic M. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial [Internet]. Lancet. 2017 ; 390( 10094): 555-566.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)31266-7
Artigo de periodico
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Fonte: Lancet. Unidades: FM, FMRP
Assuntos: PROMOÇÃO DA SAÚDE, ACORDOS INTERNACIONAIS, DESENVOLVIMENTO SUSTENTÁVEL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1423-1459, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32336-X. Acesso em: 12 nov. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1423-1459. doi:10.1016/S0140-6736(17)32336-X
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1423-1459.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)32336-X
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1423-1459.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)32336-X
Artigo de periodico
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 (2017)
Reitsma, Marissa B.; Santos, Itamar de Souza; Bensenor Isabela M.
Fonte: Lancet. Unidade: FM
Assuntos: FATORES DE RISCO, PREVALÊNCIA, DOENÇAS CARDIOVASCULARES, TABAGISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REITSMA, Marissa B. e SANTOS, Itamar de Souza e BENSENOR ISABELA M.,. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet, v. 389, n. 10082, p. 1885-1906, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)30819-X. Acesso em: 12 nov. 2024.
APA
Reitsma, M. B., Santos, I. de S., & Bensenor Isabela M.,. (2017). Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet, 389( 10082), 1885-1906. doi:10.1016/S0140-6736(17)30819-X
NLM
Reitsma MB, Santos I de S, Bensenor Isabela M. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 [Internet]. Lancet. 2017 ; 389( 10082): 1885-1906.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)30819-X
Vancouver
Reitsma MB, Santos I de S, Bensenor Isabela M. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 [Internet]. Lancet. 2017 ; 389( 10082): 1885-1906.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)30819-X
Artigo de periodico
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Goulart, Alessandra Carvalho; Furtado, João Marcello Fortes
Fonte: Lancet. Unidades: FM, HU, FMRP
Assuntos: CONTROLE DE DOENÇAS NÃO TRANSMISSÍVEIS, MORTALIDADE, EPIDEMIOLOGIA ANALÍTICA, SAÚDE PÚBLICA, CONTROLE DE DOENÇAS TRANSMISSÍVEIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1211-1259, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32154-2. Acesso em: 12 nov. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., Goulart, A. C., & Furtado, J. M. F. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1211-1259. doi:10.1016/S0140-6736(17)32154-2
NLM
Lotufo PA, Benseñor IJM, Goulart AC, Furtado JMF. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1211-1259.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)32154-2
Vancouver
Lotufo PA, Benseñor IJM, Goulart AC, Furtado JMF. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1211-1259.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)32154-2
Artigo de periodico
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Fonte: Lancet. Unidades: FM, FMRP
Assuntos: FATORES SOCIOECONÔMICOS, MORTALIDADE, EPIDEMIOLOGIA ANALÍTICA, SAÚDE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1260-1344, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32130-X. Acesso em: 12 nov. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1260-1344. doi:10.1016/S0140-6736(17)32130-X
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1260-1344.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)32130-X
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1260-1344.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)32130-X
Artigo de periodico
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Fonte: Lancet. Unidades: FM, FMRP
Assuntos: ANÁLISE GLOBAL, MORTALIDADE INFANTIL, FATORES DE RISCO, EXPECTATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article. Lancet, v. 390, n. 10100, p. 1084-1150, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)31833-0. Acesso em: 12 nov. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article. Lancet, 390( 10100), 1084-1150. doi:10.1016/S0140-6736(17)31833-0
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article [Internet]. Lancet. 2017 ; 390( 10100): 1084-1150.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)31833-0
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article [Internet]. Lancet. 2017 ; 390( 10100): 1084-1150.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)31833-0
Artigo de periodico
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants (2017)
Lotufo, Paulo A.
Fonte: Lancet. Unidade: FM
Assuntos: FATORES DE RISCO, PREVALÊNCIA, DOENÇAS CARDIOVASCULARES, HIPERTENSÃO, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet, v. 389, n. 10064, p. 37-55, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(16)31919-5. Acesso em: 12 nov. 2024.
APA
Lotufo, P. A. (2017). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet, 389( 10064), 37-55. doi:10.1016/S0140-6736(16)31919-5
NLM
Lotufo PA. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants [Internet]. Lancet. 2017 ; 389( 10064): 37-55.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(16)31919-5
Vancouver
Lotufo PA. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants [Internet]. Lancet. 2017 ; 389( 10064): 37-55.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(16)31919-5
Artigo de periodico
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Fonte: Lancet. Unidades: FM, HU, FMRP
Assuntos: EXPRESSÃO AMBIENTAL, POLÍTICAS PÚBLICAS, FATORES DE RISCO, DESENVOLVIMENTO SUSTENTÁVEL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1345-1422, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32366-8. Acesso em: 12 nov. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1345-1422. doi:10.1016/S0140-6736(17)32366-8
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1345-1422.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)32366-8
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1345-1422.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(17)32366-8
Artigo de periodico
Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study (2016)
Mehta, Ravindra L.; Burdmann, Emmanuel A.; Cerdá, Jorge; Feehally, John; Fredric Finkelstein,; García-García, Guillermo; Godin, Melanie; Jha, Vivekanand; Lameire, Norbert H.; Levin, Nathan W.; Lewington, Andrew; Lombardi, Raúl; Macedo, Etienne; Rocco, Michael; Aronoff-Spencer, Eliah; Tonelli, Marcello; Zhang, Jing; Remuzzi, Giuseppe
Fonte: Lancet. Unidade: FM
Assuntos: INSUFICIÊNCIA RENAL, ESTUDOS MULTICÊNTRICOS, FATORES DE RISCO, SINAIS E SINTOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Ravindra L. et al. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet, v. 387, n. 10032, p. 2017-2025, 2016Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(16)30240-9. Acesso em: 12 nov. 2024.
APA
Mehta, R. L., Burdmann, E. A., Cerdá, J., Feehally, J., Fredric Finkelstein,, García-García, G., et al. (2016). Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet, 387( 10032), 2017-2025. doi:10.1016/S0140-6736(16)30240-9
NLM
Mehta RL, Burdmann EA, Cerdá J, Feehally J, Fredric Finkelstein, García-García G, Godin M, Jha V, Lameire NH, Levin NW, Lewington A, Lombardi R, Macedo E, Rocco M, Aronoff-Spencer E, Tonelli M, Zhang J, Remuzzi G. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study [Internet]. Lancet. 2016 ; 387( 10032): 2017-2025.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(16)30240-9
Vancouver
Mehta RL, Burdmann EA, Cerdá J, Feehally J, Fredric Finkelstein, García-García G, Godin M, Jha V, Lameire NH, Levin NW, Lewington A, Lombardi R, Macedo E, Rocco M, Aronoff-Spencer E, Tonelli M, Zhang J, Remuzzi G. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study [Internet]. Lancet. 2016 ; 387( 10032): 2017-2025.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(16)30240-9
Artigo de periodico-carta/editorial
The olympically mismeasured risk of Zika virus in Rio de Janeiro – Authors' reply [Correspondência] (2016)
Massad, Eduardo ; Coutinho, Francisco Antonio Bezerra; Wilder-Smith, Annelies
Fonte: Lancet. Unidade: FM
Assuntos: DENGUE, PUBLICAÇÕES ACADÊMICAS, ZIKA VIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASSAD, Eduardo e COUTINHO, Francisco Antonio Bezerra e WILDER-SMITH, Annelies. The olympically mismeasured risk of Zika virus in Rio de Janeiro – Authors' reply [Correspondência]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0140-6736(16)31228-4. Acesso em: 12 nov. 2024. , 2016
APA
Massad, E., Coutinho, F. A. B., & Wilder-Smith, A. (2016). The olympically mismeasured risk of Zika virus in Rio de Janeiro – Authors' reply [Correspondência]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0140-6736(16)31228-4
NLM
Massad E, Coutinho FAB, Wilder-Smith A. The olympically mismeasured risk of Zika virus in Rio de Janeiro – Authors' reply [Correspondência] [Internet]. Lancet. 2016 ; 388( 10045): 658-659.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(16)31228-4
Vancouver
Massad E, Coutinho FAB, Wilder-Smith A. The olympically mismeasured risk of Zika virus in Rio de Janeiro – Authors' reply [Correspondência] [Internet]. Lancet. 2016 ; 388( 10045): 658-659.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(16)31228-4
Artigo de periodico-carta/editorial
Is Zika a substantial risk for visitors to the Rio de Janeiro Olympic Games? [Correspondência] (2016)
Massad, Eduardo ; Coutinho, Francisco Antonio Bezerra; Wilder-Smith, Annelies
Fonte: Lancet. Unidade: FM
Assuntos: FATORES DE RISCO, ZIKA VIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASSAD, Eduardo e COUTINHO, Francisco Antonio Bezerra e WILDER-SMITH, Annelies. Is Zika a substantial risk for visitors to the Rio de Janeiro Olympic Games? [Correspondência]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0140-6736(16)30842-X. Acesso em: 12 nov. 2024. , 2016
APA
Massad, E., Coutinho, F. A. B., & Wilder-Smith, A. (2016). Is Zika a substantial risk for visitors to the Rio de Janeiro Olympic Games? [Correspondência]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0140-6736(16)30842-X
NLM
Massad E, Coutinho FAB, Wilder-Smith A. Is Zika a substantial risk for visitors to the Rio de Janeiro Olympic Games? [Correspondência] [Internet]. Lancet. 2016 ; 388( 10039): 25.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(16)30842-X
Vancouver
Massad E, Coutinho FAB, Wilder-Smith A. Is Zika a substantial risk for visitors to the Rio de Janeiro Olympic Games? [Correspondência] [Internet]. Lancet. 2016 ; 388( 10039): 25.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(16)30842-X
Artigo de periodico-dep/entr
Microcephaly in Brazil: how to interpret reported numbers? [Comentário] (2016)
Victora, Cesar Gomes; Schuler-Faccini, Lavinia; Matijasevich, Alicia; Ribeiro, Erlane; Pessoa, André; Barros, Fernando Celso
Fonte: Lancet. Unidade: FM
Assuntos: CÉREBRO (ANORMALIDADES), ARBOVÍRUS, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICTORA, Cesar Gomes et al. Microcephaly in Brazil: how to interpret reported numbers? [Comentário]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0140-6736(16)00273-7. Acesso em: 12 nov. 2024. , 2016
APA
Victora, C. G., Schuler-Faccini, L., Matijasevich, A., Ribeiro, E., Pessoa, A., & Barros, F. C. (2016). Microcephaly in Brazil: how to interpret reported numbers? [Comentário]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0140-6736(16)00273-7
NLM
Victora CG, Schuler-Faccini L, Matijasevich A, Ribeiro E, Pessoa A, Barros FC. Microcephaly in Brazil: how to interpret reported numbers? [Comentário] [Internet]. Lancet. 2016 ; 387( 10019): 621-624.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(16)00273-7
Vancouver
Victora CG, Schuler-Faccini L, Matijasevich A, Ribeiro E, Pessoa A, Barros FC. Microcephaly in Brazil: how to interpret reported numbers? [Comentário] [Internet]. Lancet. 2016 ; 387( 10019): 621-624.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(16)00273-7
Artigo de periodico
Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development (2015)
Meara, John G.; Leather, Andrew J. M.; Hagander, Lars; Alkire, Blake C.; Alonso, Nivaldo; Ameh, Emmanuel A.; Bickler, Stephen W.; Conteh, Lesong; Dare, Anna J.; Davies, Justine; Mérisier, Eunice Dérivois; El-Halabi, Shenaaz; Farmer, Paul E.; Gawande, Atul; Gillies, Rowan; Greenberg, Sarah L. M.; Grimes, Caris E.; Gruen, Russell L.; Ismail, Edna Adan; Kamara, Thaim Buya; Lavy, Chris; Lundeg, Ganbold; Mkandawire, Nyengo C.; Raykar, Nakul P.; Riesel, Johanna N.; Rodas, Edgar; Rose, John; Roy, Nobhojit; Shrime, Mark G.; Sullivan, Richard; Verguet, Stéphane; Watters, David; Weiser, Thomas G.; Wilson, Iain H.; Yamey, Gavin; Yip, Winnie
Fonte: Lancet. Unidade: FM
Assuntos: ASSISTÊNCIA À SAÚDE, SAÚDE PÚBLICA, CIRURGIA (CONDIÇÕES ECONÔMICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEARA, John G. et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet, v. 386, n. 9993, p. 569-624, 2015Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(15)60160-X. Acesso em: 12 nov. 2024.
APA
Meara, J. G., Leather, A. J. M., Hagander, L., Alkire, B. C., Alonso, N., Ameh, E. A., et al. (2015). Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet, 386( 9993), 569-624. doi:10.1016/S0140-6736(15)60160-X
NLM
Meara JG, Leather AJM, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SLM, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Lundeg G, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development [Internet]. Lancet. 2015 ; 386( 9993): 569-624.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(15)60160-X
Vancouver
Meara JG, Leather AJM, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SLM, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Lundeg G, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development [Internet]. Lancet. 2015 ; 386( 9993): 569-624.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(15)60160-X
Artigo de periodico
Mortality risk attributable to high and low ambient temperature: a multicountry observational study (2015)
Gasparrini, Antonio; Guo, Yuming; Hashizume, Masahiro; Lavigne, Eric; Zanobetti, Antonella; Schwartz, Joel; Tobias, Aurelio; Tong, Shilu; Rocklöv, Joacim; Forsberg, Bertil; Leone, Michela; De Sario, Manuela; Bell, Michelle L.; Guo, Yue-Liang Leon; Wu, Chang-fu; Kan, Haidong; Yi, Seung-Muk; Coelho, Micheline de Sousa Zanotti Stagliorio; Saldiva, Paulo Hilário Nascimento ; Honda, Yasushi; Kim, Ho; Armstrong, Ben
Fonte: Lancet. Unidade: FM
Assuntos: MORTALIDADE, TEMPERATURA AMBIENTE, EXPOSIÇÃO AMBIENTAL, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPARRINI, Antonio et al. Mortality risk attributable to high and low ambient temperature: a multicountry observational study. Lancet, v. 386, n. 9991, p. 369-375, 2015Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(14)62114-0. Acesso em: 12 nov. 2024.
APA
Gasparrini, A., Guo, Y., Hashizume, M., Lavigne, E., Zanobetti, A., Schwartz, J., et al. (2015). Mortality risk attributable to high and low ambient temperature: a multicountry observational study. Lancet, 386( 9991), 369-375. doi:10.1016/S0140-6736(14)62114-0
NLM
Gasparrini A, Guo Y, Hashizume M, Lavigne E, Zanobetti A, Schwartz J, Tobias A, Tong S, Rocklöv J, Forsberg B, Leone M, De Sario M, Bell ML, Guo Y-LL, Wu C-fu, Kan H, Yi S-M, Coelho M de SZS, Saldiva PHN, Honda Y, Kim H, Armstrong B. Mortality risk attributable to high and low ambient temperature: a multicountry observational study [Internet]. Lancet. 2015 ; 386( 9991): 369-375.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(14)62114-0
Vancouver
Gasparrini A, Guo Y, Hashizume M, Lavigne E, Zanobetti A, Schwartz J, Tobias A, Tong S, Rocklöv J, Forsberg B, Leone M, De Sario M, Bell ML, Guo Y-LL, Wu C-fu, Kan H, Yi S-M, Coelho M de SZS, Saldiva PHN, Honda Y, Kim H, Armstrong B. Mortality risk attributable to high and low ambient temperature: a multicountry observational study [Internet]. Lancet. 2015 ; 386( 9991): 369-375.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(14)62114-0
Artigo de periodico-dep/entr
Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário] (2015)
Santos, Raul D.; Watts, Gerald F.
Fonte: Lancet. Unidade: FM
Assuntos: FATORES DE RISCO, MUTAÇÃO GENÉTICA, DOENÇAS CARDIOVASCULARES (ETIOLOGIA), HIPERCOLESTEROLEMIA (COMPLICAÇÕES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. e WATTS, Gerald F. Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0140-6736(14)61702-5. Acesso em: 12 nov. 2024. , 2015
APA
Santos, R. D., & Watts, G. F. (2015). Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0140-6736(14)61702-5
NLM
Santos RD, Watts GF. Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário] [Internet]. Lancet. 2015 ; 385( 9965): 307-310.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(14)61702-5
Vancouver
Santos RD, Watts GF. Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário] [Internet]. Lancet. 2015 ; 385( 9965): 307-310.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(14)61702-5
Artigo de periodico
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015)
Forouzanfar, Mohammad H.; Lotufo, Paulo A.; Polanczyk, Guilherme V.
Fonte: Lancet. Unidade: FM
Assuntos: FATORES DE RISCO, EXPOSIÇÃO OCUPACIONAL, PREVENÇÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOROUZANFAR, Mohammad H. e LOTUFO, Paulo A. e POLANCZYK, Guilherme V. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, v. 386, n. 10010, p. 2287-2323, 2015Tradução . . Disponível em: http://www.sciencedirect.com/science/article/pii/S0140673615001282. Acesso em: 12 nov. 2024.
APA
Forouzanfar, M. H., Lotufo, P. A., & Polanczyk, G. V. (2015). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386( 10010), 2287-2323. doi:10.1016/s0140-6736(16)31679-8
NLM
Forouzanfar MH, Lotufo PA, Polanczyk GV. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [Internet]. Lancet. 2015 ; 386( 10010): 2287-2323.[citado 2024 nov. 12 ] Available from: http://www.sciencedirect.com/science/article/pii/S0140673615001282
Vancouver
Forouzanfar MH, Lotufo PA, Polanczyk GV. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [Internet]. Lancet. 2015 ; 386( 10010): 2287-2323.[citado 2024 nov. 12 ] Available from: http://www.sciencedirect.com/science/article/pii/S0140673615001282
Artigo de periodico
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015)
Naghavi, Mohsen; Lotufo, Paulo A.
Fonte: Lancet. Unidade: FM
Assuntos: CAUSA DA MORTE (ANÁLISE), POLÍTICA DE SAÚDE, EPIDEMIOLOGIA, ESTIMATIVA DE POPULAÇÃO, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAGHAVI, Mohsen e LOTUFO, Paulo A. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, v. 385, n. 9963, p. 117-171, 2015Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(14)61682-2. Acesso em: 12 nov. 2024.
APA
Naghavi, M., & Lotufo, P. A. (2015). Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 385( 9963), 117-171. doi:10.1016/S0140-6736(14)61682-2
NLM
Naghavi M, Lotufo PA. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [Internet]. Lancet. 2015 ; 385( 9963): 117-171.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(14)61682-2
Vancouver
Naghavi M, Lotufo PA. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [Internet]. Lancet. 2015 ; 385( 9963): 117-171.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(14)61682-2
Artigo de periodico
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology (2015)
Mehta, Ravindra L.; Cerdá, Jorge; Burdmann, Emmanuel A.; Tonelli, Marcello; García-García, Guillermo; Jha, Vivekanand; Susantitaphong, Paweena; Rocco, Michael; Vanholder, Raymond; Sever, Mehmet Sukru; Cruz, Dinna; Jaber, Bertrand; Lameire, Norbert H.; Lombardi, Raúl; Lewington, Andrew; Feehally, John; Finkelstein, Fredric; Levin, Nathan; Pannu, Neesh
Fonte: Lancet. Unidade: FM
Assuntos: COLESTEROL, CORONARIOPATIA, HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Ravindra L. et al. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet, v. 385, n. 9987, p. 2616-2643, 2015Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(15)60126-X. Acesso em: 12 nov. 2024.
APA
Mehta, R. L., Cerdá, J., Burdmann, E. A., Tonelli, M., García-García, G., Jha, V., et al. (2015). International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet, 385( 9987), 2616-2643. doi:10.1016/S0140-6736(15)60126-X
NLM
Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology [Internet]. Lancet. 2015 ; 385( 9987): 2616-2643.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(15)60126-X
Vancouver
Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology [Internet]. Lancet. 2015 ; 385( 9987): 2616-2643.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/S0140-6736(15)60126-X
Artigo de periodico
Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014)
Kassebaum, Nicholas J.; Bertozzi-Villa, Amelia; Coggeshall, Megan S.; Shackelford, Katya A.; Steiner, Caitlyn; Heuton, Kyle R.; Gonzalez-Medina, Diego; Barber, Ryan; Huynh, Chantal; Dicker, Daniel; Templin, Tara; Wolock, Timothy M.; Ozgoren, Ayse Abbasoglu; Abd-Allah, Foad; Abera, Semaw Ferede; Abubakar, Ibrahim; Achoki, Tom; Adelekan, Ademola; Ademi, Zanfina; Adou, Arsène Kouablan; Adsuar, José C.; Agardh, Emilie E.; Lotufo, Paulo A.
Fonte: Lancet. Unidade: FM
Assuntos: ADULTOS, CRIANÇAS, OBESIDADE (PREVALÊNCIA), SOBREPESO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KASSEBAUM, Nicholas J. et al. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, v. 384, n. 9947, p. 766-781, 2014Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(14)60696-6. Acesso em: 12 nov. 2024.
APA
Kassebaum, N. J., Bertozzi-Villa, A., Coggeshall, M. S., Shackelford, K. A., Steiner, C., Heuton, K. R., et al. (2014). Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 384( 9947), 766-781. doi:10.1016/s0140-6736(14)60696-6
NLM
Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, Gonzalez-Medina D, Barber R, Huynh C, Dicker D, Templin T, Wolock TM, Ozgoren AA, Abd-Allah F, Abera SF, Abubakar I, Achoki T, Adelekan A, Ademi Z, Adou AK, Adsuar JC, Agardh EE, Lotufo PA. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [Internet]. Lancet. 2014 ; 384( 9947): 766-781.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/s0140-6736(14)60696-6
Vancouver
Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, Gonzalez-Medina D, Barber R, Huynh C, Dicker D, Templin T, Wolock TM, Ozgoren AA, Abd-Allah F, Abera SF, Abubakar I, Achoki T, Adelekan A, Ademi Z, Adou AK, Adsuar JC, Agardh EE, Lotufo PA. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [Internet]. Lancet. 2014 ; 384( 9947): 766-781.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/s0140-6736(14)60696-6

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos